[Successful treatment with paclitaxel of a visceral relapse of post-transplant Kaposi's sarcoma].
Succès du traitement par paclitaxel d’une rechute viscérale d’un sarcome de Kaposi après transplantation rénale.
Kaposi's sarcoma
Kidney transplantation
Paclitaxel
Sarcome de Kaposi
Transplantation rénale
Journal
Nephrologie & therapeutique
ISSN: 1872-9177
Titre abrégé: Nephrol Ther
Pays: France
ID NLM: 101248950
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
03
06
2020
revised:
23
08
2020
accepted:
11
10
2020
pubmed:
11
2
2021
medline:
29
10
2021
entrez:
10
2
2021
Statut:
ppublish
Résumé
We report the observation of a patient who presented with post-transplant Kaposi's sarcoma after a delay of eight months with a dual cutaneous and palatal localisation. The reduction in immunosuppressive treatment and the introduction of Rapamune® allowed good clinical progress initially with regression of the skin lesions. He subsequently presented later a skin relapse with visceral localisation. Chemotherapy was conducted based on weekly paclitaxel infusions allowing partial remission and maintenance of renal graft function with good clinical tolerance.
Identifiants
pubmed: 33563572
pii: S1769-7255(20)30415-6
doi: 10.1016/j.nephro.2020.10.010
pii:
doi:
Substances chimiques
Immunosuppressive Agents
0
Paclitaxel
P88XT4IS4D
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
132-136Informations de copyright
Copyright © 2020 Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.